ti.\*:("The International Congress on Immunosuppression")
Results 1 to 25 of 433
Selection :
The International Congress on ImmunosuppressionBUSUTTIL, Ronald W; NEUHAUS, Peter.Transplantation proceedings. 1998, Vol 30, Num 4, issn 0041-1345Conference Proceedings
Future challenges in immunosuppressionLAND, W.Transplantation proceedings. 1998, Vol 30, Num 4, pp 1580-1584, issn 0041-1345Conference Paper
Chronic rejectionTILNEY, N. L; KUSAKA, M; PRATSCHKE, J et al.Transplantation proceedings. 1998, Vol 30, Num 4, pp 1590-1594, issn 0041-1345Conference Paper
FK506 rescue therapy in lung transplantationWIEBE, K; HARRINGER, W; FRANKE, U et al.Transplantation proceedings. 1998, Vol 30, Num 4, pp 1508-1509, issn 0041-1345Conference Paper
Protocol liver biopsies : The case in favourNEUBERGER, J; WILSON, P; ADAMS, D et al.Transplantation proceedings. 1998, Vol 30, Num 4, pp 1497-1499, issn 0041-1345Conference Paper
Antibody induction therapy in pancreas transplantationGRUESSNER, R. W. G.Transplantation proceedings. 1998, Vol 30, Num 4, pp 1556-1559, issn 0041-1345Conference Paper
Clinical impact of neoral in heart transplantationAZIZ, T; EL-GAMEL, A; KEEVIL, B et al.Transplantation proceedings. 1998, Vol 30, Num 4, pp 1152-1153, issn 0041-1345Conference Paper
Liposomal tacrolimus : Drug migration within blood compartmentsMCALISTER, V. C.Transplantation proceedings. 1998, Vol 30, Num 4, pp 1000-1001, issn 0041-1345Conference Paper
Novel concept for easy quantification of posttransplant immunocompetenceNAGASHIMA, N; WATANABE, T; KUO, A et al.Transplantation proceedings. 1998, Vol 30, Num 4, pp 1168-1169, issn 0041-1345Conference Paper
Prevalence of malignancies after lung transplantationSPIEKERKOETTER, E; KRUG, N; HOEPER, M et al.Transplantation proceedings. 1998, Vol 30, Num 4, pp 1523-1524, issn 0041-1345Conference Paper
Activation of COL3A1 promoter activity by cyclosporineGINEVRI, F; GUSMANO, R; OLEGGINI, R et al.Transplantation proceedings. 1998, Vol 30, Num 4, pp 955-956, issn 0041-1345Conference Paper
Donor bone marrow infusion in renal transplantationCIANCIO, G; GARCIA-MORALES, R; BURKE, G. W et al.Transplantation proceedings. 1998, Vol 30, Num 4, pp 1365-1366, issn 0041-1345Conference Paper
Rapamycin's effect on vasomotion in the ratMILLIARD, S; SILVA, A; BLAISE, G et al.Transplantation proceedings. 1998, Vol 30, Num 4, pp 1036-1038, issn 0041-1345Conference Paper
The cost of rejection in liver allograft recipientsMARTIN, J. E; FLECK, P; SCHROEDER, T. J et al.Transplantation proceedings. 1998, Vol 30, Num 4, pp 1500-1501, issn 0041-1345Conference Paper
Decreasing pancreatic toxicity of tacrolimus by dosage reductionUCHIDA, K; TOMINAGA, Y; HABA, T et al.Transplantation proceedings. 1998, Vol 30, Num 4, pp 1276-1278, issn 0041-1345Conference Paper
Development of tolerance in a chronic rejection modelTULLIUS, S. G; NIEMINEN, M; BECHSTEIN, W. O et al.Transplantation proceedings. 1998, Vol 30, Num 4, pp 1075-1076, issn 0041-1345Conference Paper
Mycophenolate mofetil in lung transplantationZUCKERMANN, A; BIRSAN, T; THAGHAVI, S et al.Transplantation proceedings. 1998, Vol 30, Num 4, pp 1514-1516, issn 0041-1345Conference Paper
Tacrolimus for rescue of refractory renal allograft rejectionJORDAN, M. L; NARAGHI, R; MCMICHAEL, J et al.Transplantation proceedings. 1998, Vol 30, Num 4, pp 1257-1260, issn 0041-1345Conference Paper
CD95L confers immune privilege to liver grafts which are spontaneously acceptedFÄNDRICH, F; LIN, X; ZHU, X et al.Transplantation proceedings. 1998, Vol 30, Num 4, pp 1057-1058, issn 0041-1345Conference Paper
Effect of CsA versus FK 506 on insulin sensitivity and insulin response using a modeling techniqueSTEINMUELLER, T; KONRAD, T; VICINI, P et al.Transplantation proceedings. 1998, Vol 30, Num 4, pp 1452-1453, issn 0041-1345Conference Paper
Effects of immunosuppression and pretransplant splenectomy in newborn cardiac xenograft survivalXU, H; GUNDRY, S. R; HANCOCK, W. W et al.Transplantation proceedings. 1998, Vol 30, Num 4, issn 0041-1345, p. 1084Conference Paper
Experience with neoral cyclosporine through the oral route in liver transplantationBILBAO, I; LAZARO, J. L; POU, L et al.Transplantation proceedings. 1998, Vol 30, Num 4, pp 1432-1434, issn 0041-1345Conference Paper
FK506 for primary and rescue therapy following liver transplantationPLATZ, K. P; MUELLER, A. R; ZYTOWSKI, M et al.Transplantation proceedings. 1998, Vol 30, Num 4, pp 1409-1410, issn 0041-1345Conference Paper
High local production of nitric oxide as a possible mechanism by which rapamycin prevents transplant arteriosclerosisPHAM, S. M; SHEARS, L. L; KAWAHARADA, N et al.Transplantation proceedings. 1998, Vol 30, Num 4, pp 953-954, issn 0041-1345Conference Paper
Humanized, nonmitogenic OKT3 antibody, huOKT3γ(Ala-Ala) : Initial clinical experienceWOODLE, E. S; BLUESTONE, J. A; ZIVIN, R. A et al.Transplantation proceedings. 1998, Vol 30, Num 4, pp 1369-1370, issn 0041-1345Conference Paper